Yilei Mao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Peking Union Medical College Hospital, West China Hospital of Sichuan University · ORCID：0000-0003-0449-4223

发表论文 331 篇 · 总被引 11677 次 · h-index 47

代表论文

• 2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges (2025 · HepatoBiliary Surgery and Nutrition · 被引 56)
• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 45)
• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 41)
• Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990–2021 (2025 · The American Journal of Gastroenterology · 被引 21)
• Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models (2025 · Molecular Cancer · 被引 11)
• Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications (2025 · Clinical and Molecular Hepatology · 被引 9)